Perfil
James Schaub is currently the Chief Operating Officer & Executive Vice President at RVL Pharmaceuticals Plc since 2016.
Prior to this, he worked as the Vice President-Mergers & Acquisitions at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
He also served as the Chief Operating Officer at Trigen Laboratories LLC.
Mr. Schaub completed his undergraduate degree from Middlebury College and earned an MBA from Rutgers Business School.
Cargos activos de James Schaub
| Empresas | Cargo | Inicio |
|---|---|---|
| RVL PHARMACEUTICALS PLC | Director de Operaciones | 01/01/2016 |
Antiguos cargos conocidos de James Schaub.
| Empresas | Cargo | Fin |
|---|---|---|
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures specialty pharmaceuticals in dermatology | Corporate Officer/Principal | 01/09/2012 |
Trigen Laboratories LLC
Trigen Laboratories LLC Drugstore ChainsRetail Trade Operates as a generic pharmaceutical company | Director de Operaciones | - |
Formación de James Schaub.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures specialty pharmaceuticals in dermatology | Health Technology |
Trigen Laboratories LLC
Trigen Laboratories LLC Drugstore ChainsRetail Trade Operates as a generic pharmaceutical company | Retail Trade |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RVL Pharmaceuticals Plc
RVL Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- James Schaub
















